Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-12-14 Purchase | 2023-12-18 6:01 pm | TScan Therapeutics Inc. | TCRX | Klencke Barbara Director | 5,000 | $5.08 | $25,400 | 55,000 (Indirect Direct) | View |
| 2020-08-18 Purchase | 2020-08-18 8:16 pm | Sierra Oncology Inc. | SRRA | Klencke Barbara Chief Development Officer | 9,275 | $12.23 | $113,447 | 15,000 (Indirect Direct) | View |
| 2019-08-22 Purchase | 2019-08-26 5:07 pm | Sierra Oncology Inc. | SRRA | Klencke Barbara Chief Development Officer | 229,000 | $0.43947 | $100,638 | 229,000 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-19 Option Award | 2024-02-21 5:22 pm | N/A 2034-02-18 | eFFECTOR Therapeutics Inc. | EFTR | Klencke Barbara Director | 2,000 | $0 | 2,000 (Direct) | View |
| 2023-09-15 Option Award | 2023-09-19 4:32 pm | N/A 2033-09-15 | Xencor Inc | XNCR | Klencke Barbara Director | 40,070 | $0 | 40,070 (Direct) | View |
| 2023-06-22 Option Award | 2023-06-22 8:14 pm | N/A 2033-06-21 | eFFECTOR Therapeutics Inc. | EFTR | Klencke Barbara Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-15 6:13 pm | N/A 2033-06-12 | TScan Therapeutics Inc. | TCRX | Klencke Barbara Director | 36,524 | $0 | 36,524 (Direct) | View |
| 2023-04-06 Option Award | 2023-04-10 10:39 am | N/A 2033-04-05 | TScan Therapeutics Inc. | TCRX | Klencke Barbara Director | 9,146 | $0 | 9,146 (Direct) | View |
Ownership | 2023-04-10 10:35 am | N/A N/A | TScan Therapeutics Inc. | TCRX | Klencke Barbara Director | 0 | $0 | 50,000 (Direct) | View |
| 2023-01-20 Option Award | 2023-01-24 4:10 pm | N/A 2033-01-19 | eFFECTOR Therapeutics Inc. | EFTR | Klencke Barbara Director | 28,125 | $0 | 28,125 (Direct) | View |
| 2022-07-01 Disposition | 2022-07-01 4:43 pm | N/A N/A | Sierra Oncology Inc. | SRRA | Klencke Barbara Chief Medical Officer | 15,000 | $55 | 0 (Direct) | View |
| 2022-07-01 Disposition | 2022-07-01 4:43 pm | N/A 2025-06-10 | Sierra Oncology Inc. | SRRA | Klencke Barbara Chief Medical Officer | 332,551 | $0 | 0 (Direct) | View |
| 2022-06-17 Option Award | 2022-06-17 4:14 pm | 2022-06-17 2030-08-12 | Sierra Oncology Inc. | SRRA | Klencke Barbara Chief Medical Officer | 12,250 | $0 | 12,250 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-13 6:49 pm | N/A 2032-06-08 | eFFECTOR Therapeutics Inc. | EFTR | Klencke Barbara Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-03-14 Option Award | 2022-03-14 4:45 pm | N/A 2032-03-14 | Sierra Oncology Inc. | SRRA | Klencke Barbara Chief Medical Officer | 50,000 | $0 | 50,000 (Direct) | View |
| 2022-01-28 Option Award | 2022-01-28 6:34 pm | 2022-01-28 2030-08-12 | Sierra Oncology Inc. | SRRA | Klencke Barbara Chief Medical Officer | 12,250 | $0 | 12,250 (Direct) | View |
| 2021-11-01 Option Award | 2021-11-02 7:10 pm | N/A 2031-10-31 | eFFECTOR Therapeutics Inc. | EFTR | Klencke Barbara Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2021-03-15 Option Award | 2021-03-17 9:15 pm | N/A 2031-03-15 | Sierra Oncology Inc. | SRRA | Klencke Barbara Chief Development Officer | 30,000 | $0 | 30,000 (Direct) | View |
| 2020-02-25 Option Award | 2020-02-27 4:15 pm | N/A 2030-02-25 | Sierra Oncology Inc. | SRRA | Klencke Barbara Chief Development Officer | 167,091 | $0 | 167,091 (Direct) | View |